Oxford Asset Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,688
Closed -$121K 285
2024
Q1
$121K Buy
+20,688
New +$123K 0.13% 221
2020
Q1
Sell
-99,798
Closed -$1.6M 282
2019
Q4
$1.6M Sell
99,798
-35,759
-26% -$546K 0.04% 559
2019
Q3
$2.5M Buy
135,557
+114,384
+540% +$2.24M 0.06% 422
2019
Q2
$417K Sell
21,173
-6,060
-22% -$123K 0.01% 1343
2019
Q1
$623K Sell
27,233
-27,985
-51% -$608K 0.01% 1120
2018
Q4
$1.11M Sell
55,218
-74,148
-57% -$1.53M 0.03% 812
2018
Q3
$2.81M Sell
129,366
-3,640
-3% -$80.8K 0.06% 473
2018
Q2
$2.96M Sell
133,006
-59,637
-31% -$1.22M 0.06% 417
2018
Q1
$3.32M Buy
192,643
+26,357
+16% +$440K 0.07% 318
2017
Q4
$2.79M Sell
166,286
-2,022
-1% -$34.5K 0.06% 413
2017
Q3
$2.74M Buy
168,308
+81,432
+94% +$1.37M 0.05% 449
2017
Q2
$1.41M Sell
86,876
-46,095
-35% -$729K 0.03% 767
2017
Q1
$2.31M Sell
132,971
-78,015
-37% -$1.3M 0.06% 410
2016
Q4
$3.56M Sell
210,986
-39,175
-16% -$653K 0.13% 160
2016
Q3
$4.39M Buy
250,161
+189,444
+312% +$3.07M 0.14% 170
2016
Q2
$873K Buy
+60,717
New +$759K 0.03% 509
2015
Q1
Sell
-108,307
Closed -$2.07M 661
2014
Q4
$2.07M Buy
108,307
+83,230
+332% +$1.41M 0.05% 374
2014
Q3
$349K Sell
25,077
-34,587
-58% -$494K 0.01% 588
2014
Q2
$971K Sell
59,664
-16,360
-22% -$237K 0.03% 493
2014
Q1
$1.2M Sell
76,024
-29,643
-28% -$483K 0.03% 434
2013
Q4
$1.82M Buy
105,667
+88,840
+528% +$1.37M 0.05% 435
2013
Q3
$222K Buy
+16,827
New +$198K ﹤0.01% 732

Other funds holding ANGO

Oxford Asset Management's ANGO Position: Q2 2024 in Review

Oxford Asset Management sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 20,688 shares — an estimated $121K sold.

Oxford Asset Management first reported a position in ANGO in Q3 2013 and held it in 22 quarters. The position peaked at $4.39M in Q3 2016. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

  • Oxford Asset Management reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
  • Oxford Asset Management sold 20,688 AngioDynamics shares in Q2 2024, an estimated $121K.
  • Oxford Asset Management first reported a position in AngioDynamics in Q3 2013 and held it in 22 quarters.
  • Oxford Asset Management's AngioDynamics position peaked at $4.39M in Q3 2016.
  • 139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on Oxford Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.